Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Market Insights | Europe | 2021

The European market for EP mapping and ablation devices will experience moderate growth through 2029, particularly in the diagnostic and ablation catheter segments, largely as a result of increasing ablation volumes. However, the COVID-19 global pandemic will have a significant impact on the Europe EP mapping and ablation device market, resulting in lost procedure volumes in the short term followed by a period of recovery.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for EP mapping and ablation devices in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Cardiac Assist Devices – Market Insights – Europe
The European cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, expanded use across a broader patient…
Report
Structural Heart Closure Devices – Market Insights – Global
The global structural heart closure device market is growing steadily due to better diagnosis and increasing use of minimally invasive procedures. Structural heart closure procedures are rising,…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will see modest growth through 2035, driven by recent technological and clinical advances, including the introduction of nextgeneration devices, expanding…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period because of rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…